Bullous Pemphigoid Occurring after Stopping Imatinib Therapy of CML: Is a Continuation of Post-Treatment Follow-Up Needed?

Advancements and the use of tyrosine kinase inhibitors (TKIs) have revolutionized the treatment of Chronic Myeloid Leukemia (CML), achieving unprecedented success rates and expanding their applications to various neoplasms. However, the use of TKIs is not without its drawbacks. Skin, gastrointestina...

Descripción completa

Detalles Bibliográficos
Autores principales: Yakobson, Alexander, Neime, Ala Eddin, Abu Saleh, Omar, Al Athamen, Kayed, Shalata, Walid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514788/
https://www.ncbi.nlm.nih.gov/pubmed/37736932
http://dx.doi.org/10.3390/clinpract13050096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514788/
https://www.ncbi.nlm.nih.gov/pubmed/37736932
http://dx.doi.org/10.3390/clinpract13050096

Ejemplares similares